Three-dimensional models of neurotransmitter transporters and their interactions with cocaine and S-citalopram

World Journal of Biological Psychiatry

Volumn 7, Issue 2, 2006, Pages 99-109

  Ravna, Aina Westrheim ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Cocaine; Molecular modelling; S citalopram; Secondary transporter; Three dimensional structure

Indexed keywords

CITALOPRAM; COCAINE; DOPAMINE TRANSPORTER; LACTOSE PERMEASE; MONOAMINE OXIDASE INHIBITOR; NEUROTRANSMITTER; NORADRENALIN; PROTON; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SODIUM ION; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; COCAINE DEPENDENCE; DEPRESSION; DRUG ABUSE; DRUG INDICATION; DRUG PROTEIN BINDING; DRUG SELECTIVITY; DRUG TARGETING; ESCHERICHIA COLI; GENE MUTATION; GENE TARGETING; HUMAN; LIGAND BINDING; MOLECULAR MECHANICS; MOLECULAR MODEL; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING;

ANTIDEPRESSIVE AGENTS; CITALOPRAM; COCAINE; DEPRESSIVE DISORDER; MODELS, MOLECULAR; NEUROTRANSMITTER TRANSPORT PROTEINS; PROTEIN CONFORMATION; REWARD;

EID: 33646677715     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970500402144     Document Type: Article

References (64)

1. Abramson, J and Smirnova, I and Kasho, V and Verner, G and Kaback, HR and Iwata, S. (2003) Structure and mechanism of the lactose permease of Escherichia coli Science, 301, pp. 610-615.
2. 3H Cocaine labels a binding site associated with the serotonin transporter in guinea pig brain: Allosteric modulation by paroxetine Neurochem Res, 17, pp. 1275-1283.
3. Bardo, MT. (1998) Neuropharmacological mechanisms of drug reward: Beyond dopamine in the nucleus accumbens Crit Rev Neurobiol, 12, pp. 37-67.
4. Barker, EL and Blakely, RD.(1995) Norepinephrine and serotonin transporters: Molecular targets of antidepressant drugs. In Psychopharmacology: The fourth generation of progress. (pp. 321-334). New York: Raven Press.
5. Barker, EL and Moore, KR and Rakhshan, F and Blakely, RD. (1999) Transmembrane domain I contributes to the permeation pathway for serotonin and ions in the serotonin transporter J Neurosci, 19, pp. 4705-4717.
6. Barker, EL and Perlman, MA and Adkins, EM and Houlihan, WJ and Pristupa, ZB and Niznik, HB and Blakely, RD. (1998) High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis. An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol J Biol Chem, 273, pp. 19459-19468.
7. Barnes, NM and Sharp, T. (1999) A review of central 5-HT receptors and their function Neuropharmacology, 38, pp. 1083-1152.
8. Boja, JW and Vaughan, R and Patel, A and Shaya, EK and Kuhar, MJ.(1994) The dopamine transporter. In Dopamine receptors and transporters. (pp. 611-644). New York: Marcel Dekker.
9. Chalmers, AF.(2002) What is this thing called science?. Buckingham: Open University Press.
10. Chang, AS and Starnes, DM and Chang, SM. (1998) Possible existence of quaternary structure in the high-affinity serotonin transport complex Biochem Biophys Res Commun, 249, pp. 416-421.
11. Chang, G and Roth, CB. (2001) Structure of MsbA from E. coli: A homolog of the multidrug resistance ATP binding cassette (ABC) transporters Science, 293, pp. 1793-1800.
12. Chen, JG and Sachpatzidis, A and Rudnick, G. (1997) The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding J Biol Chem, 272, pp. 28321-28327.
13. Dahl, SG and Edvardsen, O and Sylte, I. (1991) Molecular dynamics of dopamine at the D2 receptor Proc Natl Acad Sci USA, 88, pp. 8111-8115.
14. Dahl, SG and Sylte, I and Ravna, AW. (2004) Structures and models of transporter proteins J Pharmacol Exp Ther, 309, pp. 853-860.
15. + antiporter in Escherichia coli Proc Natl Acad Sci USA, 90, pp. 1212-1216.
16. Gerchman, Y and Rimon, A and Padan, E. (1999) A pH-dependent conformational change of NhaA Na(+)/H(+) antiporter of Escherichia coli involves loop VIII-IX, plays a role in the pH response of the protein, and is maintained by the pure protein in dodecyl maltoside J Biol Chem, 274, pp. 24617-24624.
17. Gerchman, Y and Rimon, A and Venturi, M and Padan, E. (2001) Oligomerization of NhaA, the Na+/H+ antiporter of Escherichia coli in the membrane and its functional and structural consequences Biochemistry, 40, pp. 3403-3412.
18. Giros, B and el Mestikawy, S and Godinot, N and Zheng, K and Han, H and Yang-Feng, T and Caron, MG. (1992) Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter Mol Pharmacol, 42, pp. 383-390.
19. Hall, FS and Li, XF and Sora, I and Xu, F and Caron, M and Lesch, KP and Murphy, DL and Uhl, GR. (2002) Cocaine mechanisms: Enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions Neuroscience, 115, pp. 153-161.
20. Hastrup, H and Karlin, A and Javitch, JA. (2001) Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment Proc Natl Acad Sci USA, 98, pp. 10055-10060.
21. Hibert, MF and Trumpp-Kallmeyer, S and Bruinvels, A and Hoflack, J. (1991) Three-dimensional models of neurotransmitter G-binding protein-coupled receptors Mol Pharmacol, 40, pp. 8-15.
22. Horschitz, S and Hummerich, R and Schloss, P. (2001) Structure, function and regulation of the 5-hydroxytryptamine (serotonin) transporter Biochem Soc Trans, 29, pp. 728-732.
23. Huang, Y and Lemieux, MJ and Song, J and Auer, M and Wang, DN. (2003) Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli Science, 301, pp. 616-620.
24. Hyttel, J. (1994) Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs) Int Clin Psychopharmacol, 9(Suppl 1), pp. 19-26.
25. + antiporter (NhaA) from Escherichia coli FEBS Lett, 363, pp. 264-268.
26. Jess, U and El Far, O and Kirsch, J and Betz, H. (2002) Interaction of the C-terminal region of the rat serotonin transporter with MacMARCKS modulates 5-HT uptake regulation by protein kinase C Biochem Biophys Res Commun, 294, pp. 272-279.
27. Kaback, HR and Wu, J. (1997) From membrane to molecule to the third amino acid from the left with a membrane transport protein Q Rev Biophys, 30, pp. 333-364.
28. Kilic, F and Rudnick, G. (2000) Oligomerization of serotonin transporter and its functional consequences Proc Natl Acad Sci USA, 97, pp. 3106-3111.
29. Kitayama, S and Morita, K and Dohi, T and Wang, JB and Davis, SC and Uhl, GR. (1996) Dissection of dopamine and cocaine binding sites on the rat dopamine transporter expressed in COS cells Ann NY Acad Sci, 801, pp. 388-393.
30. Kitayama, S and Shimada, S and Xu, H and Markham, L and Donovan, DM and Uhl, GR. (1992) Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding Proc Natl Acad Sci USA, 89, pp. 7782-7785.
31. + antiporter from Vibrio parahaemolyticus J Bacteriol, 179, pp. 7600-7602.
32. Lee, SH and Chang, MY and Lee, KH and Park, BS and Lee, YS and Chin, HR. (2000) Importance of valine at position 152 for the substrate transport and 2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane binding of dopamine transporter Mol Pharmacol, 57, pp. 883-889.
33. Lin, J and Thompson, DS. (2001) Treating premenstrual dysphoric disorder using serotonin agents J Womens Health Gend Based Med, 10, pp. 745-750.
34. Lin, Z and Wang, W and Kopajtic, T and Revay, RS and Uhl, GR. (1999) Dopamine transporter: Transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition Mol Pharmacol, 56, pp. 434-447.
35. Lin, Z and Zhang, PW and Zhu, X and Melgari, JM and Huff, R and Spieldoch, RL and Uhl, GR. (2003) Phosphatidylinositol 3-kinase, protein kinase C, and MEK1/2 kinase regulation of dopamine transporters (DAT) require N-terminal DAT phosphoacceptor sites J Biol Chem, 278, pp. 20162-20170.
36. Locher, KP and Lee, AT and Rees, DC. (2002) The E. coli BtuCD structure: a framework for ABC transporter architecture and mechanism Science, 296, pp. 1091-1098.
37. Manji, HK and Duman, RS. (2001) Impairments of neuroplasticity and cellular resilience in severe mood disorders: Implications for the development of novel therapeutics Psychopharmacol Bull, 35, pp. 5-49.
38. Mitsuhata, C and Kitayama, S and Morita, K and Vandenbergh, D and Uhl, GR and Dohi, T. (1998) Tyrosine-533 of rat dopamine transporter: involvement in interactions with 1-methyl-4-phenylpyridinium and cocaine Brain Res Mol Brain Res, 56, pp. 84-88.
39. Murakami, S and Nakashima, R and Yamashita, E and Yamaguchi, A. (2002) Crystal structure of bacterial multidrug efflux transporter AcrB Nature, 419, pp. 587-593.
40. + antiporter (NhaA) from Escherichia coli by random mutagenesis J Biochem (Tokyo), 121, pp. 661-670.
41. + antiporter of Escherichia coli is exposed and faces the cell exterior J Biol Chem, 272, pp. 1761-1768.
42. + antiporter of Escherichia coli, a key transporter in the adaptation to Na+ and H+ Novartis Found Symp, 221, pp. 183-196.
43. + circulation in cells J Bioenerg Biomembr, 25, pp. 647-669.
44. + antiporter in Escherichia coli J Exp Biol, 196, pp. 443-456.
45. Palczewski, K and Kumasaka, T and Hori, T and Behnke, CA and Motoshima, H and Fox, BA and Le Trong, I and Teller, DC and Okada, T and Stenkamp, RE and Yamamoto, M and Miyano, M. (2000) Crystal structure of rhodopsin: A G protein-coupled receptor Science, 289, pp. 739-745.
46. + antiporter from Escherichia coli FEBS Lett, 365, pp. 18-22.
47. Ramamoorthy, S and Bauman, AL and Moore, KR and Han, H and Yang-Feng, T and Chang, AS and Ganapathy, V and Blakely, RD. (1993) Antidepressant- and cocaine-sensitive human serotonin transporter: Molecular cloning, expression, and chromosomal localization Proc Natl Acad Sci USA, 90, pp. 2542-2546.
48. Ravna, AW and Sylte, I and Dahl, SG. (2003a) Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters J Pharmacol Exp Ther, 307, pp. 34-41.
49. + antiporter NhaA Receptors Channels, 7, pp. 319-328.
50. Ravna, AW and Sylte, I and Dahl, SG. (2003b) Molecular model of the neural dopamine transporter J Comput Aided Mol Des, 17, pp. 367-382.
51. Ravna, AW and Sylte, I and Kristiansen, K and Dahl, SG. (2006) Putative drug binding conformations of monoamine transporters Bioorg Med Chem, 14, pp. 666-675.
52. Reizer, J and Reizer, A and Saier, MH, Jr. (1994) A functional superfamily of sodium/solute symporters Biochim Biophys Acta, 1197, pp. 133-166.
53. + antiporter as well as the growth phenotype of Escherichia coli J Biol Chem, 273, pp. 26470-26476.
54. + antiporter from Escherichia coli J Biol Chem, 271, pp. 32288-32292.
55. Schildkraut, JJ. (1965) The catecholamine hypothesis of affective disorders: A review of supporting evidence Am J Psychiatry, 122, pp. 509-522.
56. Stahl, SM. (1998) Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects J Affect Disord, 51, pp. 215-235.
57. Sur, C and Betz, H and Schloss, P. (1998) Distinct effects of imipramine on 5-hydroxytryptamine uptake mediated by the recombinant rat serotonin transporter SERT1 J Neurochem, 70, pp. 2545-2553.
58. + antiporter coded by nhaA (ant) from Escherichia coli J Biol Chem, 266, pp. 11289-11294.
59. Tatsumi, M and Groshan, K and Blakely, RD and Richelson, E. (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters Eur J Pharmacol, 340, pp. 249-258.
60. Torres, GE and Carneiro, A and Seamans, K and Fiorentini, C and Sweeney, A and Yao, WD and Caron, MG. (2003) Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter J Biol Chem, 278, pp. 2731-2739.
61. Toyoshima, C and Nakasako, M and Nomura, H and Ogawa, H. (2000) Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 A resolution Nature, 405, pp. 647-655.
62. Uhl, G and Lin, Z and Metzger, T and Dar, DE. (1998) Dopamine transporter mutants, small molecules, and approaches to cocaine antagonist/dopamine transporter disinhibitor development Methods Enzymol, 296, pp. 456-465.
63. Uhl, GR and Hall, FS and Sora, I. (2002) Cocaine, reward, movement and monoamine transporters Mol Psychiatry, 7, pp. 21-26.
64. Williams, KA. (2000) Three-dimensional structure of the ion-coupled transport protein NhaA Nature, 403, pp. 112-115.